- #1,673 Suresh G Kare ₹1,100 Cr

About Warren Remedies Private Limited
Data last updated:
Warren Remedies Private Limited is a private limited company based in Aurangabad, Maharashtra, India, a subsidiary of Indoco Remedies Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 June 2022.
Its director Suresh G Kare is #1,673 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2022PTC384184. Its GSTIN is 27AADCW2799L1ZK (Maharashtra). The company holds 6 GST registrations, all of them active.
The company has an authorised share capital of ₹30 Cr and a paid-up capital of ₹15 Cr. It is led by directors including Amulya Ranjan Nayak (Whole-Time Director) and Sundeep Vasant Bambolkar.
Its last annual general meeting (AGM) was held on 10 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Aurangabad, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹98.74 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹37.77 Cr (net margin -38.2%) and EBITDA of -₹8.33 Cr (EBITDA margin -8.4%).
The company has about 405 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹239 Cr on record. The company has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹10 Cr; the latest was in August 2022. Its 10 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 5 smaller; the largest is Vineet Life Sciences Limited with revenue of ₹101.85 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website warrenremedies.com.
Company details
Recognitions & Rankings of Warren Remedies
Contact details
Warren Remedies Private Limited's registered office is in Aurangabad, Maharashtra. Its website is warrenremedies.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No – 17 Auric Shendra, Sector No – 13 Shendra MIDC, Aurangabad, Maharashtra, India – 431154
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Warren Remedies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Warren Remedies is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Warren Remedies Private Limited, buy the company report.
Financials of Warren Remedies Private Limited
FY 2025 filings availableWarren Remedies Private Limited reported revenue of ₹98.74 Cr (up 2320% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹8.33 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹37.77 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -8.4% | ||
| Net Profit Margin | -38.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Warren Remedies Private Limited, buy the company report.
Board of directors of Warren Remedies Private Limited
Warren Remedies has 5 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sundeep Vasant Bambolkar | Director | 07 Jun 2022 | 4 Years 5 Months | Current |
| Aditi Milind Panandikar Also directs: Indoco Remedies Limited, Xtend Industrial Designers and Engineers Private Limited, A K Services & Agency Private Limited and 1 more | Director | 07 Jun 2022 | 4 Years 5 Months | Current |
| Ulhas Anant Joshi Also directs: Redeem Water India LLP, Visdem Technosys Limited | Director | 01 Apr 2024 | 2 Years 7 Months | Current |
| Amulya Ranjan Nayak | Whole-Time Director | 14 May 2024 | 2 Years 6 Months | Current |
| Suresh Govind Kare Also directs: Indoco Remedies Limited, Spa Holdings Private Limited, Shanteri Investment Private Limited and 1 more | Additional Director | 05 Nov 2025 | 1 Years 0 Months | Current |
Peer comparison
Warren Remedies Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vineet Life Sciences Limited | ₹101.85 Cr (FY 2024) | 48.0% | Hyderabad, Telangana, India | |||
| Sna Healthcare Private Limited | ₹101.57 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Sarv Bio Labs Private Limited | ₹101.4 Cr (FY 2024) | -10.0% | Himachal Pradesh, India | |||
| Valens Molecules Private Limited | ₹100.32 Cr (FY 2025) | 0.0% | Hyderabad, Telangana, India | |||
| Ketul Chem Private Limited | ₹98.92 Cr (FY 2025) | 12.0% | Mumbai, Maharashtra, India | |||
| Warren Remedies Private Limitedthis company | ₹98.74 Cr (FY 2025) | -₹37.77 Cr | -38.2% | 2320.0% | 405 | Aurangabad, Maharashtra, India |
| Benova Labs Private Limited | ₹98.59 Cr (FY 2025) | -6.0% | Hyderabad, Telangana, India | |||
| Teena Labs Limited | ₹96.94 Cr (FY 2024) | -46.0% | Hyderabad, Telangana, India | |||
| B G P Healthcare Private Limited | ₹95.66 Cr (FY 2025) | -1.0% | Ankleshwar, Gujarat, India | |||
| Virupaksha Laboratories Private Limited | ₹94.74 Cr (FY 2024) | 12.0% | Hyderabad, Telangana, India | |||
| Aurore Pharmaceuticals Private Limited | ₹94.5 Cr (FY 2025) | 1.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Warren Remedies Private Limited, buy the company report.
Auditor
Warren Remedies Private Limited is audited by D. S. Mahambre & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D. S. Mahambre & Co | FY 2023 | 105754W |
Shareholding
The shareholding of Warren Remedies Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Warren Remedies Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jul 2024 | 100953748 | Hdfc Bank Limited | ₹25 Cr | Open | |
| 08 Jul 2024 | 100952896 | Hdfc Bank Limited | ₹125 Cr | Open | |
| 19 Oct 2023 | 100802809 | Standard Chartered Bank | ₹89 Cr | Open |
To see the full charge records of Warren Remedies Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Warren Remedies Private Limited has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹10 Cr; the latest was in August 2022.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2022 | Rights issue | ₹4.99 Cr | Investors: Indoco Remedies Limited |
| Aug 2022 | Funding round | ₹10 Cr | Investors: Indoco Remedies Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Warren Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Warren Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Warren Remedies Private Limited has a workforce of 405 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 405 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Warren Remedies Private Limited, buy the company report.
GST
Warren Remedies has 6 GST registrations: 6 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCW2799L1ZK | Maharashtra | Active | 09 Aug 2022 |
| 27AADCW2799L2ZJ | Maharashtra | Active | 16 Sep 2024 |
| 29AADCW2799L1ZG | Karnataka | Active | 07 Feb 2024 |
| 36AADCW2799L1ZL | Telangana | Active | 13 Feb 2024 |
To see the full GST registrations and return filing status of Warren Remedies Private Limited, buy the company report.
Recent activity
Warren Remedies Private Limited has 9 board changes on record since 2022: 6 appointments and 3 cessations. The latest: Suresh Govind Kare was appointed as Additional Director on 05 Nov 2025.
5 earlier events are in the company report.
Frequently asked questions
Warren Remedies is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 June 2022 (4+ years old) and is registered under CIN U24304MH2022PTC384184.
Warren Remedies has 5 current directors:
- Amulya Ranjan Nayak - Whole-Time Director
- Sundeep Vasant Bambolkar - Director
- Aditi Milind Panandikar - Director
- Ulhas Anant Joshi - Director
- Suresh Govind Kare - Additional Director
The latest financial statements of Warren Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 10 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Warren Remedies is 27AADCW2799L1ZK, registered in Maharashtra. The company has 6 GST registrations in all, of which 6 are active. Other active GSTINs include 27AADCW2799L2ZJ (Maharashtra), 29AADCW2799L1ZG (Karnataka), 36AADCW2799L1ZL (Telangana).
The CIN (Corporate Identification Number) of Warren Remedies is U24304MH2022PTC384184. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Warren Remedies was incorporated on 07 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Warren Remedies has 2 deals on record (1 rights issue, 1 funding round), with disclosed funding of ₹10 Cr; the latest was in August 2022.
The peers of Warren Remedies by revenue are Vineet Life Sciences Limited, Sna Healthcare Private Limited, Sarv Bio Labs Private Limited, Valens Molecules Private Limited, Ketul Chem Private Limited and 5 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Suresh Govind Kare was appointed as Additional Director on 05 Nov 2025. Ulhas Anant Joshi ceased to be Additional Director on 23 Sep 2024. Amulya Ranjan Nayak was appointed as Whole-Time Director on 14 May 2024. Warren Remedies has 9 board changes on record in total.
Warren Remedies can be reached through the website warrenremedies.com. Its registered office is in Aurangabad, Maharashtra, India.
The registered office of Warren Remedies is at Plot No – 17 Auric Shendra, Sector No – 13 Shendra MIDC, Aurangabad, Maharashtra, India – 431154.

